Call for Abstract
Scientific Program
3rd International Conference on Pharmaceutical Regulatory Affairs, will be organized around the theme “Embracing Recent Strategies in Global Regulatory Affairs”
Regulatory Affairs-2013 is comprised of 9 tracks and 62 sessions designed to offer comprehensive sessions that address current issues in Regulatory Affairs-2013.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 4-1Legal requirements of an IND application
- Track 4-2Role of clinical trials in drug development
- Track 4-3Internal IND review principles, policies and procedure
- Track 4-4Regulatory forms and submissions
- Track 4-5Laws and regulations
- Track 5-1Biologics
- Track 5-2Blood and blood products
- Track 5-3Gene therapy and cloning
- Track 5-4Radiopharmaceuticals
- Track 5-5OTC drug products, herbal medicines, homeopathic medicines
- Track 5-6Vaccines
- Track 5-7Scheduled drugs
- Track 5-8Medical affairs
- Track 6-1Quality risk management system
- Track 7-1The business of pharmacy, medicine and biotechnology
- Track 7-2Regulatory culture in Food and Drug Administration
- Track 7-3Biomedical product development: From boardroom to market
- Track 7-4Importance of personnel training and education in regulatory affairs
- Track 7-5Pharmacoeconomics & outcomes research
- Track 7-6Medical entrepreneurship
- Track 7-7Marketing authorizations
- Track 7-8Product advertising and promotion
- Track 9-1Regulatory issues, quality control, and business development
- Track 9-2Clinical trials in emerging markets
- Track 9-3Benefit/risk assessment during drug development
- Track 9-4Strategic development towards FDA approval
- Track 9-5Regulatory challenges in nano and biotech therapeutics